IUS Publications

Found 5 results
Filters: Author is Una Glamočlija  [Clear All Filters]
2024
M. Dedić, Omeragić, E., Imamović, B., Bilajac, E., Mahmutović, L., Glamočlija, U., and Bečić, E., “HPLC method for the determination of thymoquinone in growth cell medium”, Technology and Health Care, vol. Pre-press, pp. 1-14, 2024.
2023
E. Bilajac, Glamočlija, U., Osmanović, A., Mahmutovic, L., Sezer, A., Roca, S., Špirtović-Halilović, S., Salihović, M., Hromic-Jahjefendic, A., and Veljović, E., “Analysis of Antitumor Potential of Xanthene Compounds in Lymphoma Cells”, Croatica Chemica Acta, vol. 96, 2023.
E. Bilajac, Glamočlija, U., Osmanović, A., Mahmutovic, L., Sezer, A., Roca, S., Salihović, M., Hromic-Jahjefendic, A., and Veljović, E., “Analysis of Antitumor Potential of Xanthene Compounds in Lymphoma Cells”, Croatica Chemica Acta, 2023.
2022
E. Bilajac, Mahmutovic, L., Glamočlija, U., Osmanović, A., Hromic-Jahjefendic, A., Tambuwala, M., and Suljagic, M., “Curcumin Decreases Viability and Inhibits Proliferation of Imatinib-Sensitive and Imatinib-Resistant Chronic Myeloid Leukemia Cell Lines”, MDPI Metabolites, 2022.
E. Bilajac, Mahmutovic, L., Glamočlija, U., Osmanović, A., Hromic-Jahjefendic, A., Tambuwala, M. M., and Suljagic, M., “Curcumin Decreases Viability and Inhibits Proliferation of Imatinib-Sensitive and Imatinib-Resistant Chronic Myeloid Leukemia Cell Lines”, MDPI Metabolites, vol. 13, 2022.